Answers are grounded in this paper and cite their sources.
Degenerative cervical myelopathy (DCM) is the leading cause of spinal cord dysfunction in adults. Although surgical decompression alleviates symptoms, many patients experience persistent neurological deficits, and the underlying mechanisms remain unclear. Here, we established a mouse model of DCM and found that inflammatory microglia persistently colonize the lesion core, showing lipid droplet accumulation, lysosomal overload, and senescence. Microglial replacement by bone marrow transplantation eliminated these cells, promoted vascular and axonal regrowth, and restored neurological function. Cerebrospinal fluid proteomics from DCM patients revealed downregulation of lipid metabolism proteins, including HADHB, a mitochondrial enzyme essential for long-chain fatty acid β-oxidation. Consistently, Hadhb was markedly reduced in inflammatory microglia of DCM mice. Knockdown of Hadhb in homeostatic microglia recapitulated lipid accumulation, inflammatory activation, and senescence, whereas microglia-specific overexpression of Hadhb during decompression suppressed the inflammatory phenotype and strongly improved neurological outcomes. These findings identify Hadhb deficiency as a critical driver of microglial lipid metabolic failure that impedes neurological recovery, highlighting a novel therapeutic target for DCM. Moreover, restoration of Hadhb function may represent a post-surgical adjunct therapy for this disabling condition.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: